Inclisiran is administered via subcutaneous injection. The dosing regimen typically involves an initial dose followed by a second dose at three months, and subsequent doses every six months. This biannual dosing is a distinctive feature that contributes to its appeal as a long-term therapy for managing high cholesterol.
